Clinical Trial Update: ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate Cancer [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study comparing ODM-201 with androgen deprivation therapy in men with hormone-naive prostate cancer; the trial is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ODM-201 (darolutamide)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING